Addison Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Addison Advisors's VRTX Position: Q2 2026 in Review
Addison Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 98% in Q2 2026, selling an estimated $142K and leaving 7 shares worth $3.48K. The position accounts for ﹤0.01% of the portfolio, ranked #526.
Addison Advisors first reported a position in VRTX in Q4 2021 and has held it in 19 quarters since. The position peaked at $174K in Q1 2025. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Addison Advisors held 7 shares of Vertex Pharmaceuticals worth $3.48K as of Q2 2026.
- Addison Advisors sold 321 Vertex Pharmaceuticals shares in Q2 2026, an estimated $142K.
- Vertex Pharmaceuticals made up ﹤0.01% of Addison Advisors's portfolio in Q2 2026, its #526 holding.
- Addison Advisors first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
- Addison Advisors's Vertex Pharmaceuticals position peaked at $174K in Q1 2025.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Addison Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.